modality XPLR 2.0.0 masterclass: from 6‑base data to multiomic features and disease insight
See how modality XPLR 2.0.0 turns your duet pipeline outputs into features that help distinguish healthy from disease, in your compute environment.
Robert Blanshard, Ph.D.
Product Manager, biomodal
6-base sequencing delivers genetics, 5mC and 5hmC and fragmentomics from the same molecule, and the duet portfolio gives you all that without trading away accuracy, biological insight or workflow simplicity. The next question is what you do with it.
In this masterclass, you’ll watch Robert Blanshard take real multiomic data through modality XPLR 2.0.0: extracting features, revealing patterns of health and disease, and linking epigenetic changes to the biology behind them. The demonstration starts with biological QC, differential methylation analysis, extraction and visualization of methylation and fragmentomics features, before showing examples of insight generation using compatible community tools. The session is followed by a live Q&A.
modality XPLR works directly on duet analysis pipeline outputs, and runs efficiently on a laptop or HPC so you can dive into data quickly. No subscriptions, no black box. Your data, your compute, your choice.
modality XPLR is included with every duet kit from biomodal.
What you will learn
- How 6-base sequencing and the duet portfolio deliver genetic, epigenetic and fragmentomic information from one workflow
- What the duet analysis pipeline produces, and how modality XPLR enables exploration of methylation and fragmentomics data
- The importance of biological QC for methylation analysis
- How to run DMR calling and visualize gene-level insights in modality Viewer
- How to generate classifier-ready feature tables for downstream tools
Who should attend
modality XPLR’s low-code interface is suitable for everyone from translational researchers running biomodal assays to experienced bioinformaticians and data scientists.
Related Webinars
Teach me in 10: 5mC and 5hmC are synergistic biomarkers for early detection of colorectal cancer
Robert Osborne, PhD, Senior Vice President of Research & Development provides a high-level overview of biomodal's bioRxiv preprint, 5mC and 5hmC are synergistic biomarkers for early detection of colorectal cancer.
See morePart 1: Understanding the dynamics of enhancer DNA methylation during cellular differentiation
Join Emily Hodges, PhD, Assistant Professor of Biochemistry at Vanderbilt University, to learn more about how the Hodges Lab utilises 6-base genome to investigate the dynamics of enhancer DNA methylation during cellular differentiation.
See moreReveal the power of the 6-base genome and explore 5mC and 5hmC in Parkinson's disease in the brain
Burleen Chhatwal from University College London, UK, will demonstrate how biomodal's 6-base genome supported the successful analysis of both 5mC and 5hmC modifications in Parkinson's disease compared to controls in a pilot study.
See moreYour data, your compute, your choice
modality XPLR works directly on duet analysis pipeline outputs and runs efficiently on a laptop or HPC. It’s included with every duet kit from biomodal.
Learn more about modality XPLRRegister for the modality XPLR 2.0.0 masterclass
Wednesday, December 2, 2026 · 12:00 PM ET